Trial
NCT04543994
Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcerative Colitis (UC)
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
The Cleveland Clinic
Collaborators
Mesoblast, Inc.
Condition
Ulcerative Colitis
Intervention
Remestemcel-L
Why stopped
PI left Cleveland Clinic
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-16